Keiko Tanaka‐Amino

Factors Affecting Doses of Roxadustat Versus Darbepoetin Alfa for Anemia in Nondialysis Patients

Tadao Akizawa, Keiko Tanaka‐Amino, Tetsuro Otsuka et al. · American Journal of Nephrology · 2021 · 24 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16

Vasomotor symptoms, sleep problems, and depressive symptoms in community‐dwelling Japanese women

Makiko Tomida, Rei Otsuka, Chikako Tange et al. · Journal of obstetrics and gynaecology research · 2021 · 23 citations · Full text

Education, Endocrinology, Geriatric Medicine +15

Original Research: Potential of urinary nephrin as a biomarker reflecting podocyte dysfunction in various kidney disease models

Yusuke Wada, Masaki Abe, Hiroshi Moritani et al. · Experimental Biology and Medicine · 2016 · 19 citations · Full text

Medicine, Nephrology, Pharmacology +17

Effects of neurokinin 3 receptor antagonist fezolinetant on hot flash-like symptoms in ovariectomized rats

Atsuo Tahara, Hajime Takamatsu, Akiyoshi Ohtake et al. · European Journal of Pharmacology · 2021 · 17 citations

Medicine, Neuroscience, Pharmacology +7

Clinical parameters among patients in Japan with anemia and non-dialysis-dependent chronic kidney disease with and without diabetes mellitus who received roxadustat

Tadao Akizawa, Keiko Tanaka‐Amino, Tetsuro Otsuka et al. · Clinical and Experimental Nephrology · 2022 · 13 citations · Full text

Medicine, Hematology, Pharmacotherapy +13